Ghent’s MRM Health raises €55M to accelerate clinical development of next-gen microbiome drugs — TFN
Ghent-headquartered clinical-stage biotech company MRM Health gets €55M capital injection in a Series B financing round led by French pharmaceutical group Biocodex. The funding also saw strong participation from German-based ATHOS and new investor BNP Paribas Fortis Private Equity. Existing investors include SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II,... Read More














:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


Recent Comments